Morgan, R. J., Synold, T. W., Longmate, J. A., Quinn, D. I., Gandara, D., Lenz, H., . . . Newman, E. M. (2015). Pharmcodynamics (PD) and Pharmacokinetics (PK) of E7389 (Eribulin, Halichondrin B Analog) During a Phase I Trial in Patients with Advanced Solid Tumors: A California Cancer Consortium Trial. Cancer Chemother Pharmacol.
Citação norma ChicagoMorgan, Robert J., et al. "Pharmcodynamics (PD) and Pharmacokinetics (PK) of E7389 (Eribulin, Halichondrin B Analog) During a Phase I Trial in Patients With Advanced Solid Tumors: A California Cancer Consortium Trial." Cancer Chemother Pharmacol 2015.
Citação norma MLAMorgan, Robert J., et al. "Pharmcodynamics (PD) and Pharmacokinetics (PK) of E7389 (Eribulin, Halichondrin B Analog) During a Phase I Trial in Patients With Advanced Solid Tumors: A California Cancer Consortium Trial." Cancer Chemother Pharmacol 2015.